David Peiris

About Professor David Peiris

Chief Scientist

  • Professor, Faculty of Medicine, UNSW Sydney
  • MBBS(hons),
  • MIPH,
  • PhD,
  • FRACGP,
  • FARGP

Professor Peiris plays a lead role in developing and implementing the institute’s research strategy. He is a Professor in the Faculty of Medicine, UNSW Sydney, and is a locum GP with Miwatj Health visiting Galiwin’ku, Elcho Island.

David is passionate about strengthening primary health care worldwide. He is focussed on overcoming the challenges of delivering affordable, high-quality health services and programs to communities across the globe. His research is underpinned by health systems science, a dynamic and emerging discipline that includes health services research, health policy and systems research, and implementation science.

David has published extensively and leads several grants testing innovative strategies to improve access to high-quality primary health care. He is a former Australian Harkness Fellow in Healthcare Policy, based at the Harvard School of Public Health, and was the elected co-chair of the Global Alliance for Chronic Diseases Committee for Hypertension Control from 2012 to 2015. He sits on several government, non-government and research advisory committees. He is a Lancet commissioner focussed on evidence-based implementation in global health and pandemic preparedness.

“I would be very proud to be part of an initiative that didn’t exclude people because it was hard”: mapping and contextualising health equity responsibilities and decision-making tensions in the implementation of a multi-level system reform initiative

International Journal for Equity in Health Date published:

Using primary and routinely collected data to determine prevalence and patterns of multimorbidity in rural China: a representative cross-sectional study of 6474 Chinese adults

The Lancet Regional Health - Western Pacific Date published:

Mental Health Care Support in Rural India

JAMA Psychiatry Date published:

Use of SGLT2 Inhibitors and Glucagon-Like Peptide 1 (GLP-1) Receptor Agonists in Australian Primary Care Patients with Type 2 Diabetes Mellitus (T2DM) Stratified by CKD Status

Journal of the American Society of Nephrology Date published:

Related Readings